Background: Drug-target interactions (DTIs) prediction becomes more and more important for accelerating drug research and drug repositioning. Drug-target interaction network is a typical model for DTIs prediction. As many different types of relationships exist between drug and target, drug-target interaction network can be used for modeling drug-target interaction relationship. Recent works on drug-target interaction network are mostly concentrate on drug node or target node and neglecting the relationships between drug-target.Results: We propose a novel prediction method for modeling the relationship between drug and target independently. Firstly, we use different level relationships of drugs and targets to construct feature of drug-target interaction. Then, we use line graph to model drug-target interaction. After that, we introduce graph transformer network to predict drug-target interaction.Conclusions: This method introduces a line graph to model the relationship between drug and target. After transforming drug-target interactions from links to nodes, a graph transformer network is used to accomplish the task of predicting drug-target interactions.
20 January 2025 in Journal of Chemical Information and Modeling
Rare variants contribute significantly to the genetic causes of complex traits, as they can have much larger effects than common variants and account for much of the missing heritability in genome-wide association studies. The emergence of UK Biobank scale datasets and accurate gene-level rare variant–trait association testing methods have dramatically increased the number of rare variant associations that have been detected. However, no systematic collection of these associations has been carried out to date, especially at the gene level. To address the issue, we present the Rare Variant Association Repository (RAVAR), a comprehensive collection of rare variant associations. RAVAR includes 95 047 high-quality rare variant associations (76186 gene-level and 18 861 variant-level associations) for 4429 reported traits which are manually curated from 245 publications. RAVAR is the first resource to collect and curate published rare variant associations in an interactive web interface with integrated visualization, search, and download features. Detailed gene and SNP information are provided for each association, and users can conveniently search for related studies by exploring the EFO tree structure and interactive Manhattan plots. RAVAR could vastly improve the accessibility of rare variant studies. RAVAR is freely available for all users without login requirement at http://www.ravar.bio.
The identification of forest pests is of great significance to the prevention and control of the forest pests' scale. However, existing datasets mainly focus on common objects, which limits the application of deep learning techniques in specific fields (such as agriculture). In this paper, we collected images of forestry pests and constructed a dataset for forestry pest identification, called Forestry Pest Dataset. The Forestry Pest Dataset contains 31 categories of pests and their different forms. We conduct several mainstream object detection experiments on this dataset. The experimental results show that the dataset achieves good performance on various models. We hope that our Forestry Pest Dataset will help researchers in the field of pest control and pest detection in the future.
22 December 2023 in IEEE Journal of Biomedical and Health Informatics
Text classification is a central part of natural language processing, with important applications in understanding the knowledge behind biomedical texts including electronic health records (EHR). In this paper, we propose a novel heterogeneous graph convolutional network method for classifying EHR texts. Our method, called EHR-HGCN, is able to combine context-sensitive word and sentence embeddings with structural sentence-level and word-level relation information to perform text classification. EHR-HGCN reframes EHR text classification as a graph classification task to better capture structural information about the document using a heterogeneous graph. To mine contextual information from a document, EHR-HGCN first applies a bidirectional recurrent neural network (BiRNN) on word embeddings obtained via Global Vectors for word representation (GloVe) to obtain context-sensitive wordlevel and sentence-level embeddings. To mine structural relationships from the document, EHR-HGCN then constructs a heterogeneous graph over the word and sentence embeddings, where sentence-word and word-word relationships are represented by graph edges. Finally, a heterogeneous graph convolutional neural network is used to classify documents by their graph representation. We evaluate EHR-HGCN on a variety of standard text classification benchmarks and find that EHR-HGCN has higher accuracy and F1-score than other representative machine learning and deep learning methods. We also apply EHRHGCN to the MedLit benchmark and find it performs with high accuracy and F1-score on the task of section classification in EHR texts. Our ablation experiments show that the heterogeneous graph construction and heterogeneous graph convolutional network are critical to the performance of EHR-HGCN
11 March 2025 in IEEE Journal of Biomedical and Health Informatics
Artificial intelligence techniques play a pivotal role in the accurate identification of drug-drug interaction (DDI) events, thereby informing clinical decisions and treatment regimens. While existing DDI prediction models have made significant progress by leveraging sequence features such as chemical substructures, targets, and enzymes, they often face limitations in integrating and effectively utilizing multi-modal drug representations. To address these limitations, this study proposes a novel multi-modal feature fusion model for DDI event prediction: MMDDI-SSE. Our approach integrates drug sequence modality with DDI graph representations through a novel architecture that employs static subgraph generation to capture structural properties. The model utilizes a graph autoencoder architecture to learn both local and global topological features from these subgraphs, while simultaneously processing diverse sequence-based characteristics including semantically enhanced pharmacodynamic features, chemical substructures, target proteins, and enzyme information. Through comprehensive evaluation on two distinct datasets, MMDDI-SSE demonstrates superior predictive performance compared to state-of-the-art baselines. Ablation studies further validate the effectiveness of each architectural component in enhancing DDI prediction accuracy. The implementation code and datasets are available at https://github.com/Tomchen1231/MMDDI-SSE.